OMER Q2 2024 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$59M

Net Income

-$56M

EPS (Diluted)

$-0.97

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$356M

Total Liabilities

$481M

Stockholders' Equity

-$125M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$59M	-$41M	-44.6%
Net Income	-$56M	-$37M	-50.3%